跳至主要内容
临床试验/CTRI/2022/02/040134
CTRI/2022/02/040134尚未招募4 期

Effects of levosimendan or milrinone on left atrial pressure in patients undergoing off-pump coronary artery bypass grafting: a randomized controlled trial

IPGMER and SSKM Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Triple vessel disease fulfilling the criteria for OPCAB
  • Ejection fraction (EF) 35-55%

排除标准

  • I. Patientâ??s refusal
  • ii. Known allergy to any of the drug
  • iii. NYHA Grade 4
  • iv. Presence of haemodynamically significant arrhythmia
  • v. Left main coronary artery involvement
  • vi. Presence of hepatic / renal disease
  • vii. Presence of neurological disease

研究者

发起方
IPGMER and SSKM Hospital

相似试验